The WACC of Eiger BioPharmaceuticals Inc (EIGR) is 9.0%.
Range | Selected | |
Cost of equity | 17.30% - 26.00% | 21.65% |
Tax rate | -% - -% | -% |
Cost of debt | 7.00% - 9.30% | 8.15% |
WACC | 7.6% - 10.3% | 9.0% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 2.93 | 3.78 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 17.30% | 26.00% |
Tax rate | -% | -% |
Debt/Equity ratio | 15.51 | 15.51 |
Cost of debt | 7.00% | 9.30% |
After-tax WACC | 7.6% | 10.3% |
Selected WACC | 9.0% | |